Cargando…

Stereotactic Body Radiotherapy Is Effective in Modifying the Tumor Genome and Tumor Immune Microenvironment in Non-Small Cell Lung Cancer or Lung Metastatic Carcinoma

BACKGROUND AND PURPOSE: To directly reveal the change in genome mutation, RNA transcript of tumor cells, and tumor microenvironment (TME) after stereotactic body radiotherapy (SBRT) in paired human lung tumor specimens. MATERIALS AND METHODS: Paired tumor samples were collected from 10 patients with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Pu, Chen, Diangang, Zhu, Bo, Chen, Wei, Xie, Qichao, Wang, Yali, Tan, Qiulin, Yuan, Bibo, Zuo, Xuejiao, Huang, Changlin, Zhu, Hongfan, Li, Guanghui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862546/ https://www.ncbi.nlm.nih.gov/pubmed/33552051 http://dx.doi.org/10.3389/fimmu.2020.594212

Ejemplares similares

Outcomes after stereotactic body radiotherapy for lung tumors, with emphasis on comparison of primary lung cancer and metastatic lung tumors
por: Yamamoto, Takaya, et al.
Publicado: (2014)

Analysis of Biologically Equivalent Dose of Stereotactic Body Radiotherapy for Primary and Metastatic Lung Tumors
por: Park, Sungkwang, et al.
Publicado: (2014)

Effect of stereotactic radiotherapy on immune microenvironment of lung cancer
por: Xiao, Yao, et al.
Publicado: (2022)

Choice of immobilization of stereotactic body radiotherapy in lung tumor patient by BMI
por: Chen, Guofu, et al.
Publicado: (2019)

Stereotactic Body Radiotherapy for Small Lung Tumors in the University of Tokyo Hospital
por: Yamashita, Hideomi, et al.
Publicado: (2014)

Stereotactic body radiotherapy for central lung tumors, yes we can!
por: Korzets ceder, Yasmin, et al.
Publicado: (2018)

Predictive factors of symptomatic radiation pneumonitis in primary and metastatic lung tumors treated with stereotactic ablative body radiotherapy
por: Kim, Kangpyo, et al.
Publicado: (2017)

Stereotactic ablative body radiotherapy with a central high dose using CyberKnife for metastatic lung tumors
por: Hayashi, Kazuhiko, et al.
Publicado: (2023)

Interfractional Variations of Tumor Centroid Position and Tumor Regression during Stereotactic Body Radiotherapy for Lung Tumor
por: Sun, Yanan, et al.
Publicado: (2014)

Stereotactic radiotherapy for lung oligometastases
por: Falcinelli, Lorenzo, et al.
Publicado: (2022)

Salvage Pulmonary Operations Following Stereotactic Body Radiotherapy for Small Primary and Metastatic Lung Tumors: Evaluation of the Operative Procedures
por: Hamakawa, Hiroshi, et al.
Publicado: (2018)

Radiation-induced organizing pneumonia after stereotactic body radiotherapy for lung tumor
por: Ochiai, Satoru, et al.
Publicado: (2015)

Migration of implanted markers for image‐guided lung tumor stereotactic ablative radiotherapy
por: Hong, Julian C., et al.
Publicado: (2013)

Feasibility of Adaptive MR-guided Stereotactic Body Radiotherapy (SBRT) of Lung Tumors
por: Padgett, Kyle R, et al.
Publicado: (2018)

Stereotactic body radiotherapy (SBRT) for central and ultracentral node-negative lung tumors
por: Owen, Dawn, et al.
Publicado: (2020)

Outcomes of Stereotactic Body Radiotherapy for Metastatic Colorectal Cancer With Oligometastases, Oligoprogression, or Local Control of Dominant Tumors
por: Ji, Xiaoqin, et al.
Publicado: (2021)

Single fraction computed tomography-guided high-dose-rate brachytherapy or stereotactic body radiotherapy for primary and metastatic lung tumors?
por: Chan, Mark KH, et al.
Publicado: (2018)

Stereotactic body radiotherapy for metastatic sarcoma to the lung: adding to the arsenal of local therapy
por: Gutkin, Paulina M., et al.
Publicado: (2023)

Clinical Outcomes of Stereotactic Body Radiotherapy for Patients with Lung Tumors in the State of Oligo-Recurrence
por: Inoue, Tetsuya, et al.
Publicado: (2012)

Late tumor pseudoprogression followed by complete remission after lung stereotactic ablative radiotherapy
por: Stauder, Michael C, et al.
Publicado: (2013)

Stereotactic body radiotherapy in patients with lung tumors composed of mainly ground-glass opacity
por: Onishi, Hiroshi, et al.
Publicado: (2020)

Adaptive hypofractionted and stereotactic body radiotherapy for lung tumors with real-time MRI guidance
por: Bryant, John M., et al.
Publicado: (2023)

Feasibility of Proton Transmission-Beam Stereotactic Ablative Radiotherapy versus Photon Stereotactic Ablative Radiotherapy for Lung Tumors: A Dosimetric and Feasibility Study
por: Mou, Benjamin, et al.
Publicado: (2014)

Time course and predictive factors for lung volume reduction following stereotactic ablative radiotherapy (SABR) of lung tumors
por: Binkley, Michael S., et al.
Publicado: (2016)

Clinical experience with lung-specific electromagnetic transponders for real-time tumor tracking in lung stereotactic body radiotherapy
por: Jaccard, Maud, et al.
Publicado: (2019)

Early variations in lymphocytes and T lymphocyte subsets are associated with radiation pneumonitis in lung cancer patients and experimental mice received thoracic irradiation
por: Zhou, Pu, et al.
Publicado: (2020)

The Role of Conventionally Fractionated Radiotherapy and Stereotactic Radiotherapy in the Treatment of Carcinoid Tumors and Large-Cell Neuroendocrine Cancer of the Lung
por: Bilski, Mateusz, et al.
Publicado: (2021)

Stereotactic Body Radiotherapy for Metastatic Lung Cancer as Oligo-Recurrence: An Analysis of 42 Cases
por: Takahashi, Wataru, et al.
Publicado: (2012)

Stereotactic body radiotherapy for adenoid cystic carcinoma metastatic to the lung: a case report
por: Kobayashi, Daijiro, et al.
Publicado: (2021)

Stereotactic Radiosurgery and Stereotactic Radiotherapy for Malignant Skull Base Tumors
por: Mori, Yoshimasa, et al.
Publicado: (2020)

Respiratory Gating during Stereotactic Body Radiotherapy for Lung Cancer Reduces Tumor Position Variability
por: Saito, Tetsuo, et al.
Publicado: (2014)

Lung tumor motion change during stereotactic body radiotherapy (SBRT): an evaluation using MRI
por: Saito, Anneyuko I., et al.
Publicado: (2014)

Influence of patient's physiologic factors and immobilization choice with stereotactic body radiotherapy for upper lung tumors
por: Sio, Terence T., et al.
Publicado: (2014)

Stereotactic ablative radiotherapy for ultra-central lung tumors: prioritize target coverage or organs at risk?
por: Murrell, Donna H., et al.
Publicado: (2018)

Simulation of dosimetric consequences of intrafraction variation of tumor drift in lung cancer stereotactic body radiotherapy
por: Han, Bin, et al.
Publicado: (2022)

Predictors of chest wall toxicity after stereotactic ablative radiotherapy using real-time tumor tracking for lung tumors
por: Park, Younghee, et al.
Publicado: (2017)

Multiple Primary Lung Cancers: Treatment Outcomes After Stereotactic Body Radiotherapy (SBRT)
por: Choi, Gyujae, et al.
Publicado: (2023)

Stereotactic body radiotherapy in lung cancer: an update
por: Abreu, Carlos Eduardo Cintra Vita, et al.
Publicado: (2015)

Harmonization of dose prescription for lung stereotactic radiotherapy
por: Beldjoudi, Guillaume, et al.
Publicado: (2022)

Editorial: Stereotactic body radiotherapy for lung cancer
por: Liu, An, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tle9aubnp2tra4jgdck00oenmv